Self-Reported Eczema Valid for Detecting Atopic Dermatitis

This article originally appeared here.
Share this content:
Self-Reported Eczema Valid for Detecting Atopic Dermatitis
Self-Reported Eczema Valid for Detecting Atopic Dermatitis

MONDAY, July 27, 2015 (HealthDay News) -- Self- and caregiver-reported history of eczema is valid for identifying atopic dermatitis (AD), according to a study published online July 17 in the British Journal of Dermatology.

Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues performed a prospective multicenter dermatology practice-based study at three sites to examine the validity of caregiver- and self-reported ever and one-year history of eczema. Unselected patients were surveyed with questionnaires. Seven hundred eighty-two patients were then assessed by expert dermatologists.

The researchers found that, compared with a physician diagnosis of AD at that visit, caregiver-reported one-year history of childhood eczema had a sensitivity, specificity, and positive predictive value (PPV) of 0.70, 0.96, and 0.87, respectively. The corresponding values were 0.70, 0.95, and 0.76 for self-reported one-year history of adult eczema. Ever-history of caregiver- and self-reported eczema had high specificity (0.89 and 0.97, respectively) and PPV (0.81 and 0.91, respectively), with high sensitivity in children but not adults (0.83 versus 0.43).

"Self- and caregiver-reported diagnosis of eczema ever or in the past year based on a single question demonstrates sufficient validity for the epidemiological study of AD," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »